Press Releases

First Health Advisory Announces Rick LeMay as Executive Vice President of Enterprise Security & Technology

First Health Advisory recently welcomed Rick LeMay as its Executive Vice President of Enterprise Security & Technology to help advance the company's mission of providing digital health risk assurance to healthcare organizations.

Huateng Pharma Launches Gastrointestinal API Intermediates: Fexuprazan and Vonoprazan Intermediates

Huateng Pharma, a leading pharmaceutical ingredient manufacturer, has introduced a new product line, Gastrointestinal API Intermediates, featuring Fexuprazan and Vonoprazan Intermediates. These intermediates are designed to meet the increasing demand for high-quality solutions in gastrointestinal therapy. The products are available in both GMP and Non-GMP grades, boasting exceptional purity to facilitate the production of top-tier pharmaceuticals.

Biopharma PEG: Your Premier Source for High-Purity Monodispersed PEGs

Biopharma PEG announces a robust inventory of monodispersed PEGs, including mPEG36-NH2, NH2-PEG24-COOH, and more, catering to the pharmaceutical industry's diverse needs. These high-purity products, certified under EXCIPACT GMP standards with purity exceeding 95%, are ideal for ADCs, PROTACs, and drug delivery systems, reinforcing Biopharma PEG as a top-tier provider for pharmaceutical researchers and developers.

WCG Raises the Bar in Quality Management Standards, Becoming ISO 9001 Certified in both IRB and IBC

WCG has now achieved ISO 9001 certification for its Institutional Biosafety Committee (IBC) services as well as its Institutional Review Board (IRB) services, emphasizing its commitment to excellence in quality management across ethical review.

Veramed expands its global footprint by acquiring Data Management, Biostatistics and Medical Writing services company Clinical Trial Data Services (CTDS)

Specialist Biometrics CRO, Veramed, today announced the acquisition of Boston-based data management, biostatistics and medical writing company, CTDS.

4D Path Formalizes Partnership with Innovation Pop-Up at Leeds Teaching Hospitals NHS Trust

Collaboration aims to advance the use of adjunct diagnostics in digital pathology for accelerated, democratized precision medicine in cancer care

AVIA’s National Generative AI Collaborative Grows to Nearly Thirty Major Health Systems

BioIVT Elevates Cell and Gene Therapy to an Artform at Meeting on the Mesa

Expert staff will be on hand at the conference to discuss how BioIVT can support CGT research from discovery and development to commercialization.

BioIVT to Host a Webinar on Optimizing Liquid Biopsy Research

Webinar will discuss the importance of using standardized collection protocols and a diverse donor base to validate biomarkers and ensure their clinical utility.

Baylor Genetics to Present Scientific Research Findings at Upcoming NORD, NSGC and ASHG Conferences

10 Baylor Genetics abstracts accepted for presentation at three top genetic conferences, focusing on topics ranging from Whole Genome and Whole Exome Sequencing to Carrier Screening and Non-Invasive Prenatal Testing

Creative Proteomics Launches State-of-the-Art Peptide Sequencing Service to Advance Proteomics Research

New hot start isothermal mixes boost sensitivity, specificity, and speed of DNA target detection

PCR Biosystems, a leading PCR reagent developer, has launched a new range of Bst polymerase reagents that offer greater sensitivity, speed, and specificity in all isothermal amplification applications.

Creative Proteomics Introduces Mature Solutions for Membrane Protein Identification

Creative Proteomics Leads the Way with Cutting-Edge RNA Pull Down Service

Coya Therapeutics Licenses Exclusive Worldwide rights to Exosome Engineering Technology (EET) from Carnegie Mellon University (CMU)

Novel proprietary EET platform extends Coya Therapeutics' pipeline beyond Neurodegenerative disorders to include autoimmune disorders and cancer while expanding Coya’s optionality for potential non-dilutive business development and strategic partnerships with companies seeking novel ways to deliver cargo/drugs in a targeted fashion.

Cytel continues expansion of market access and medical communication capabilities with the acquisition of co.faktor

Cytel Inc. has acquired the Berlin-based company co.faktor GmbH.

Creative Biostructure Announces New Method for Producing CRAL-TRIO Domain-Containing Proteins Using Virus-Like Particles

Matexcel Launches New Line of Natural Extract Peptide Products for Research Use

Profacgen Announces New Technology for Membrane Protein Production

Creative Enzymes Unveils Custom Blends Product Line for Bioprocessing Solutions